The Outcome of Living-donor Versus Deceased-donor Liver Transplantation for Hepatocellular Carcinoma A Systematic Review and Meta-analysis

Abstract

epatocellular carcinoma (HCC) is the most common primary malignancy of the liver and a major cause of mortality. Therapeutic treatment options are available for patients with local disease and include ablation, resection, and liver transplantation (LT). Liver transplantation (LT) is a recognized treatment choice for patients with cirrhosis of the liver and hepatocellular carcinoma (HCC). However, the greatest challenge in liver transplant is the shortage of donors that has contributed to a remarkable increase of the waiting lists.